Cara Therapeutics | Despesas Operacionais



Operating Expenses Alterar Data
Acadia Pharmaceuticals USD 225.03M 118.93M 2025-03
Cassava Sciences USD 29.49M 1.14M 2024-12
Chugai Pharma JPY 151.81B 26.86B 2025-03
Cipla INR 55.01B 1.37B 2025-03
Clal Biotechnology ILS 5.15M 9.47M 2022-12
Compugen USD 8.95M 3.68M 2024-12
CSL USD 5.72B 173M 2024-12
Grifols EUR 1.6B 128.03M 2024-12
Halozyme Therapeutics USD 123.33M 819K 2025-03
J&J USD 8.26B 10.37B 2025-03
Neurocrine Biosciences USD 485.7M 47.4M 2024-12
Pacira USD 166.93M 4.38M 2025-03
Pfizer USD 10.05B 8.12B 2025-03
RedHill Biopharma USD 5.51M 1.08M 2024-06
Supernus Pharmaceuticals USD 152.75M 17.91M 2024-12



Cara Therapeutics Despesas Operacionais - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Jul 2025.